LRMR   $7.07  -0.98% Market Closed After Close 7.07 0.0

Larimar Therapeutics Inc
Total Cash 226.06M
totalCashPerShare 3.543
EBITDA -65.51M
Total Debt 5.59M
quickRatio 10.722
currentRatio 10.926
Total Revenue
debtToEquity 2.647
Revenue/Share
ROA -0.23587999
ROE -0.37476003
grossProfits
freeCashflow -22.43M
operatingCashflow -42.94M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 238.94M
forwardPE -3.2261307
floatShares 31.93M
sharesOutstanding 63.81M
sharesShort 3.47M
sharesShortPriorMonth 3.48M
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.08%
Short Ratio help_outline 11.93%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue 3.313
Price To Book help_outline 1.94
earningsQuarterlyGrowth
netIncomeToCommon -58.34M
trailingEps -1.12%
forwardEps -1.99%
enterpriseToEbitda -3.65
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.38 3Q 2024
institutionsCount 143
lastUpdated Sept. 16, 2024, 7:54 p.m.